
全球首款六价轮状病毒疫苗获批上市
Recently, the oral six-valent reassortant rotavirus live attenuated vaccine (Vero cells) developed by China National Pharmaceutical Group Wuhan Institute of Biological Products (brand name: WuShengEr LunBao®) has officially been approved for marketing by the National Medical Products Administration. This product is the world's first and highest-priced rotavirus vaccine, classified as a Category 1 new drug for preventive biological products in China, primarily used for the prevention of acute gastroenteritis in infants and young children caused by rotavirus
